Abliva AB

Sweden


 
Total IP 40
Total IP Rank # 35,009
IP Activity Score 2.2/5.0    20
IP Activity Rank # 41,041
Stock Symbol
ISIN SE0002575340
Market Cap. 235.7M  (SEK)
Dominant Nice Class Pharmaceutical, veterinary and s...

Patents

Trademarks

14 5
6 1
2 7
5
 
Last Patent 2024 - Kl1333 for use in medicine
First Patent 2011 - Sanglifehrin based compounds
Last Trademark 2020 - ABLIVA
First Trademark 2007 - NP

Industry (Nice Classification)

Latest Inventions, Goods, Services

2022 Invention Succinate prodrug, compositions containing the succinate prodrug and uses thereof. The present in...
Invention Kl1333 for use in medicine. The present invention relates to i) KL1333 for us...
Invention Kl1333 for use in medicine. The present invention relates to i) KL1333 for use in the treatment o...
2021 Invention Novel cell-permeable succinate compounds. The present invention provides novel cell-permeable su...
2020 G/S Medical research; research in the field of biotechnology; research in the field of genetic engine...
G/S Medical research; research relating to biotechnology; clinical research in the field of mitochond...
G/S Medical research; research relating to biotechnology; clinical research; conducting clinical tri...
G/S Medical research; Research relating to biotechnology; Clinical research; Conducting clinical tria...
G/S Chemical preparations for pharmaceutical purposes; Medicines for human purposes; Pharmaceutical d...
2018 G/S esters for foodstuffs, not for pharmaceutical purposes. Fungicides, herbicides; preparations for ...
G/S esters for foodstuffs, not for pharmaceutical purposes. Acetates for pharmaceutical purposes; aci...
G/S [ Acetates for pharmaceutical purposes; acids for pharmaceutical purposes; adjuvants for medical ...
G/S Esters for veterinary use; esters for veterinary purposes; esters for foodstuffs, not for pharma...
G/S esters for foodstuffs, not for pharmaceutical purposes. Fungicides, herbicides; other preparation...
G/S Acetates for pharmaceutical purposes; acids for pharmaceutical purposes; adjuvants for medical pu...
2017 Invention Use of sanglifehrin macrocyclic analogues as anticancer compounds. The present invention relates ...
2016 Invention Succinate prodrugs for use in the treatment of lactic acidosis or drug-induced side-effects due t...
2015 Invention Cell-permeable succinate compounds. The present invention provides novel cell-permeable succinate...
Invention Novel cell-permeable succinate compounds. The present invention provides novel cell-permeable suc...
2014 G/S Pharmaceutical preparations for medical use consisting of a cyclosporin or another cyclophilin i...
2013 Invention Protected succinates for enhancing mitochondrial atp-production. 2 is independently a group accor...
2012 Invention Dosage form. There is provided inter alia a pharmaceutical dosage form for oral administration co...
Invention Macrocyclic compounds and methods for their production. There is provided inter alia compounds of...
Invention Compound and methods for its production. There is provided inter alia a compound of formula (I): ...
Invention Macrocyclic compound and methods for its production. There is provided inter alia a compound of f...
G/S Pharmaceutical preparations for medical use consisting of a cyclosporin as active agent and dilue...
2011 Invention Sanglifehrin derivatives and methods for their production. There are provided inter alia compound...
Invention Cyclosporine emulsion. The present invention relates to a cyclosporine emulsion containing: i) a ...
Invention Sanglifehrin based compounds. There are provided inter alia compounds of formula (I) useful as ...
2007 G/S Pharmaceutical and veterinary preparations; including medicines and pharmaceutical preparations ...
G/S Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic...